PSX:NYSEPhillips 66 Analysis
Data as of 2026-05-25 - not real-time
$177.69
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Phillips 66 is trading at $177.69, comfortably above its 20‑day ($174.60) and 50‑day ($172.19) moving averages and well above the 200‑day SMA ($146.88), confirming a strong bullish bias. The MACD line sits at 2.57 above its signal (2.30) and the RSI is at a neutral 55, indicating room for further upside without immediate overbought pressure. Technicals are reinforced by a support level near $163.13 and a resistance ceiling around $184.72, suggesting a near‑term upside potential of roughly 5.5% as reflected in the computed upside/downside metric. Fundamentals show a PE of 17.5 versus an industry average of 21.6, positioning the stock as relatively cheap on a value basis, while the dividend yield of 2.86% and a payout ratio under 50% support a sustainable income stream. Recent earnings have outperformed expectations, with analysts upgrading sentiment and highlighting a $8 billion debt‑paydown plan through 2027, which should improve balance‑sheet resilience. However, the company carries a high debt‑to‑equity of 91, a negative free‑cash‑flow figure and operates in the volatile energy sector, exposing it to regulatory and transition risks. Volatility remains elevated at 35% over the past 30 days, though beta is low, indicating limited correlation with broader market moves. The consensus recommendation is a “Buy” with a median target of $190, reinforcing the upside thesis. Overall, Phillips 66 blends modest growth prospects from a refining up‑cycle with solid dividend appeal, but investors should monitor debt reduction progress and macro‑energy dynamics.
In the short term, the confluence of bullish technicals, earnings beat, and a modest upside ceiling makes a buying opportunity attractive. Over the medium horizon, the company’s strategic focus on debt reduction, renewable fuels, and a resilient dividend supports a continued positive stance, while long‑term considerations must weigh sector transition risks and the high leverage profile.
In the short term, the confluence of bullish technicals, earnings beat, and a modest upside ceiling makes a buying opportunity attractive. Over the medium horizon, the company’s strategic focus on debt reduction, renewable fuels, and a resilient dividend supports a continued positive stance, while long‑term considerations must weigh sector transition risks and the high leverage profile.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 9/10
Key Factors
- Price above 20‑day and 50‑day SMAs with bullish MACD
- Earnings beat and upgraded analyst sentiment
- Visible upside to resistance (~5.5%) and attractive dividend yield
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Debt‑paydown plan targeting $8 B reduction by 2027
- Refining up‑cycle and solid segment profitability
- Sustainable dividend supported by earnings and cash flow
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- High leverage and negative free cash flow
- Energy transition and regulatory exposure
- Diversification into renewable fuels and midstream assets
Key Metrics & Analysis
Financial Health
Revenue Growth6.90%
Profit Margin3.07%
P/E Ratio17.5
ROE14.55%
ROA3.80%
Debt/Equity91.39
P/B Ratio2.5
Op. Cash Flow$2.5B
Free Cash Flow$-1134499968
Industry P/E21.6
Technical Analysis
TrendBullish
RSI55.3
Support$163.13
Resistance$184.72
MA 20$174.60
MA 50$172.19
MA 200$146.88
MACDBullish
VolumeStable
Fear & Greed Index91.61
Valuation
Fair Value$21.74
Target Price$187.42
Upside/Downside5.48%
GradeUndervalued
TypeBlend
Dividend Yield2.86%
Risk Assessment
Beta0.02
Volatility35.19%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.